FDA's new digital tool captures real-world data from patients News item 17 November 2018 Pages: 2 - 2
Analysing acute medication use and productivity losses in migraine Clinical study 17 November 2018 Pages: 4 - 4
Direct-acting antiviral therapy for hepatitis C saves costs in Italy Clinical study 17 November 2018 Pages: 10 - 10
Disparities in access to therapies for metastatic melanoma Clinical study 17 November 2018 Pages: 11 - 11
Early ART improves outcomes at acceptable cost in Spain Clinical study 17 November 2018 Pages: 12 - 12
Edoxaban recommended for stroke prevention in AF in Thailand Clinical study 17 November 2018 Pages: 13 - 13
Eltrombopag preferred in child and adult immune thrombocytopenia Clinical study 17 November 2018 Pages: 14 - 14
Financial incentives to reduce HIV viral suppression cost effective Clinical study 17 November 2018 Pages: 15 - 15
Impact of co-payment on choice of asthma controller medicine Clinical study 17 November 2018 Pages: 17 - 17
Increased survival in melanoma comes at significant cost Clinical study 17 November 2018 Pages: 18 - 18
Outpatient parental antibacterials in children save costs Clinical study 17 November 2018 Pages: 23 - 23
Pharmacist-administered influenza vaccinations save cost Clinical study 17 November 2018 Pages: 24 - 24
Poor control of severe asthma − controller meds drive costs Clinical study 17 November 2018 Pages: 25 - 25
Price variation up to 500% across pharmacies for BPH generics in US Clinical study 17 November 2018 Pages: 26 - 26
Prosthetic implants cost effective for hip replacement Clinical study 17 November 2018 Pages: 27 - 27
Statin cost effective for CVD prevention in T2DM in China Clinical study 17 November 2018 Pages: 28 - 28
Surgery and angioplasty cost effective in multivessel CAD Clinical study 17 November 2018 Pages: 29 - 29
Tick-borne encephalitis vaccine cost effective in Sweden Clinical study 17 November 2018 Pages: 31 - 31
Unsedated endosheath transnasal endoscopy cost effective Clinical study 17 November 2018 Pages: 32 - 32
Utilisation supports same price for aflibercept and ranibizumab Clinical study 17 November 2018 Pages: 33 - 33
Voretigene neparvovec unlikely to be cost effective in USA Clinical study 17 November 2018 Pages: 34 - 34